Subject: Cambridge BioScience Accord
Date: Published: 7/24/87 24 lines
Source:  WALL STREET JOURNAL. Copyright Dow Jones & Co. Inc. 

   Cambridge BioScience Accord

   WORCESTER, Mass. -- Cambridge BioScience Corp. said it
signed an agreement to supply genetically engineered proteins
to Syntex Corp.'s Syva Co. The proteins will be used to
develop diagnostic products for acquired immune deficiency
syndrome, or AIDS, and other diseases.
   Precise terms of the agreement weren't disclosed, but
Cambridge BioScience said Syva will finance some of its
research activities and pay licensing fees to Cambridge
BioScience for the diagnostic products being developed.
   Cambridge BioScience is a biotechnology concern.  Syntex,
based in Palo Alto, Calif., makes drugs, medical diagnostic
systems and animal health products.

[This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.]